Navigation Links
Ingredient in Probiotic Sweetener Boosts Immune System
Date:4/30/2009

Nevella(R) with Probiotics developed to enhance health

INDIANAPOLIS, April 30 /PRNewswire/ -- Heartland Sweeteners LLC in conjunction with Ganeden Biotech has developed the world's first probiotic sweetener, Nevella(R) with Probiotics, which is designed to boost the immune system and promote digestive health. Additionally, according to a recently published study, the probiotic in Nevella(R) has been shown to provide some protection against certain strains of influenza.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090430/DE08669 )

With no calories, Nevella(R) with Probiotics is a healthy alternative to sugar and is a great sugar replacement in coffee, tea and baked goods.

"A healthy digestive system is key to strengthening your immune system," said Mike Servie, President of Heartland Sweeteners. "Nevella(R) with Probiotics is a great alternative to yogurt and dairy drinks that aim to improve immunity."

The partnership between Heartland Sweeteners and Ganeden Biotech, which makes the patented probiotic bacteria, GanedenBC30, was announced in March. GanedenBC30 is uniquely able to survive manufacturing and baking temperatures and maintain the health benefits of bacteria in the digestive tract. Nevella(R) with Probiotics is the first product created by the collaboration. Other offerings are in the works.

Nevella(R) with Probiotics is being distributed nationally in retail grocery stores, and is available online. For retailer and online shipping information, visit www.nevella.com.

About Heartland Sweeteners

Based in Indianapolis, Heartland Sweeteners, LLC, is a leader in the production and development of innovative food products that are great for the whole family. Heartland produces and distributes branded and private label sweeteners for the food industry. Their branded products of Nevella(R) and Ideal(TM) are great for the whole family, diabetics and people watching their calorie intake. Both Nevella(R) and Ideal(TM) are perfect for baking and are distributed throughout North America and expanding into Europe, Central and South America. Visit Heartland at www.idealsweet.com and www.nevella.com.

About Ganeden Biotech

Founded in 1997, Ganeden Biotech, Inc, is based in Cleveland, Ohio, and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage(R) and Sustenex(TM) brands. It also licenses its patented probiotic bacteria, GanedenBC30, for use in commercial food and beverage applications, medical foods, nutraceuticals and in animal health industries. Ganeden Biotech is self-affirmed GRAS (Generally Recognized As Safe) by an independent panel of experts assembled to assess its safety in use as a food ingredient. For more information about licensing, visit www.ganedenlabs.com. For probiotic supplement information, visit digestiveadvantage.com or www.sustenex.com.


'/>"/>
SOURCE Heartland Sweeteners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Active Ingredient in Marijuana Kills Brain Cancer Cells
2. Frost & Sullivan: Ageing Population and Availability of Preventative Medicines Propels Growth of European Eye Health Ingredients Market
3. Holy powder ingredient makes membranes behave for better health
4. Gold Not Only Valuable, It's a Healthy Skin Care Ingredient
5. Frost & Sullivan Recognizes Horphags Pioneering R&D Efforts in Health Ingredients
6. Desire for Performance Coupled With Natural Ingredients Boosts Botanical Actives Consumption in Personal Care
7. FDA Urges Consumers Not to Eat Hundreds of Products Recalled Because of Contaminated Peanuts and Peanut Ingredients
8. Top 10 Ingredients for Recession-Proof, Healthy Cooking
9. Z Trim to Be Distributed to Meat and Poultry Industries by World Technology Ingredients
10. Cradle to Cradle(SM) Digs Beneath the Surface with New Ingredient Certification
11. Horphag Research Receives 2008 Frost & Sullivan North American Health Ingredients Excellence In Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: